BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6864524)

  • 1. Sex differences in rats in the metabolism of phenytoin to 5-(3,4-dihydroxyphenyl)-5-phenylhydantoin.
    Billings RE
    J Pharmacol Exp Ther; 1983 Jun; 225(3):630-6. PubMed ID: 6864524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxygen-18 incorporation studies of the metabolism of phenytoin to the catechol.
    Billings RE; Fischer LJ
    Drug Metab Dispos; 1985; 13(3):312-7. PubMed ID: 2861989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for an arene oxide-NIH shift pathway in the metabolic conversion of phenytoin to 5-(4-hydroxyphenyl)-5-phenylhydantoin in the rat and in man.
    Claesen M; Moustafa MA; Adline J; Vandervorst D; Poupaert JH
    Drug Metab Dispos; 1982; 10(6):667-71. PubMed ID: 6130920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenytoin metabolism in mice.
    Chow SA; Fischer LJ
    Drug Metab Dispos; 1982; 10(2):156-60. PubMed ID: 6124402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for an arene-3,4-oxide as a metabolic intermediate in the meta- and para-hydroxylation of phenytoin in the dog.
    Moustafa MA; Claesen M; Adline J; Vandervorst D; Poupaert JH
    Drug Metab Dispos; 1983; 11(6):574-80. PubMed ID: 6140142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxylation of 5,5-diphenylhydantoin (phenytoin) by dog liver microsomes.
    Butler TC; Dudley KH; Mitchell GN; Johnson D
    Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):4-9. PubMed ID: 21639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective inhibition of diphenylhydantoin metabolism by p-hydroxyphenyl-phenylhydantoin enantiomers in rats.
    Huang JD; Hsieh CY
    Chirality; 1991; 3(6):454-9. PubMed ID: 1812955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of pregnancy and folic acid on phenytoin metabolism by rat liver microsomes.
    Blake DA; Collins JM; Miyasaki BC; Cohen F
    Drug Metab Dispos; 1978; 6(3):246-50. PubMed ID: 26544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenytoin metabolic activation: role of cytochrome P-450, glutathione, age, and sex in rats and mice.
    Roy D; Snodgrass WR
    Res Commun Chem Pathol Pharmacol; 1988 Feb; 59(2):173-90. PubMed ID: 3358010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Search for 5-(2-hydroxyphenyl)-5-phenylhydantoin as a metabolite of phenytoin.
    Poupaert JH; Moustafa M; Smeyers C; Adline J; Vandervorst D; Claesen M; Dumont P
    J Pharm Belg; 1982; 37(1):47-52. PubMed ID: 7077512
    [No Abstract]   [Full Text] [Related]  

  • 11. Bromobenzene metabolism in vivo and in vitro. The mechanism of 4-bromocatechol formation.
    Miller NE; Thomas D; Billings RE
    Drug Metab Dispos; 1990; 18(3):304-8. PubMed ID: 1974190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereochemical aspects of the metabolism of 5-(4'-fluorophenyl)-5-phenylhydantoin in the rat.
    Poupaert JH; Adline J; Claesen MH; De Laey P; Dumont PA
    J Med Chem; 1979 Sep; 22(9):1140-2. PubMed ID: 490562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regioselectivity and stereoselectivity in the metabolism of trans-1,2-dihydroxy-1,2-dihydrobenz[a]anthracene by rat liver microsomes.
    Vyas KP; van Bladeren PJ; Thakker DR; Yagi H; Sayer JM; Levin W; Jerina DM
    Mol Pharmacol; 1983 Jul; 24(1):115-23. PubMed ID: 6865920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between phenytoin, 5-(p-hydroxyphenyl)-5-phenylhydantoin and valproate in the rat.
    O'Leary TD; Sansom LN
    J Pharmacol Exp Ther; 1981 Mar; 216(3):613-6. PubMed ID: 6782238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nafimidone, an imidazole anticonvulsant, and its metabolite as potent inhibitors of microsomal metabolism of phenytoin and carbamazepine.
    Kapetanovic IM; Kupferberg HJ
    Drug Metab Dispos; 1984; 12(5):560-4. PubMed ID: 6149905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of diphenylhydantoin metabolism in different tissues using high performance liquid chromatography.
    MacKinney AA; Shinnick FL; Gorder C
    Res Commun Chem Pathol Pharmacol; 1982 Jun; 36(3):395-411. PubMed ID: 7122986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic differences in phenytoin pharmacokinetics. In vivo clearance and in vitro metabolism among inbred strains of mice.
    Atlas SA; Zweier JL; Nebert DW
    Dev Pharmacol Ther; 1980; 1(5):281-304. PubMed ID: 7438974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of phenytoin in teratogenesis-susceptible and -resistant strains of mice.
    Hansen DK; Hodes ME
    Drug Metab Dispos; 1983; 11(1):21-4. PubMed ID: 6132790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of 2-chloroethyl nitrosocarbamoylcystamine by rat liver subcellular fractions.
    Godeneche D; Madelmont JC; Moreau MF; Duprat J; Plagne R; Meyniel G
    Drug Metab Dispos; 1986; 14(1):112-7. PubMed ID: 2868853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of pregnancy on the metabolism of [14C]phenytoin in the isolated perfused rat liver.
    Vore M; Bauer J; Pascucci V
    J Pharmacol Exp Ther; 1978 Aug; 206(2):439-47. PubMed ID: 682124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.